Euryachincoside, a Novel Phenolic Glycoside with Anti-Hepatic Fibrosis Activity from Eurya chinensis
Planta Medica · 01.04.2023 · 89 (05) · 516-525
DOI: 10.1055/a-1828-2671 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.04.2023. Verfasst von Bai-Lin Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science, Guangzhou University of Chinese Medicine, Guangzhou, P. R. China. Hauptthemen laut MEDLINE: NF-kappa B, Glycosides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Eurya chinensis has been recorded as a folk medicine traditionally used for treatment of a variety of symptoms. However, the phytochemical and pharmacological investigations of this plant are still scarce. A novel phenolic glycoside named Euryachincoside (ECS) was isolated by chromatographic separation from E. chinensis, and its chemical structure was identified by analysis of HRMS and NMR data. Its anti-hepatic fibrosis effects were evaluated in both HSC-T6 (rat hepatic stellate cells) and carbon tetrachloride (CCl4)-induced mice with Silybin (SLB) as the positive control. In an in vitro study, ECS showed little cytotoxicity and inhibited transforming growth factor-beta (TGF-β)-induced Collagen I (Col1) along with alpha-smooth muscle actin (α-SMA) expressions in HSC-T6. An in vivo study suggested ECS significantly ameliorated hepatic injury, secretions of inflammatory cytokines, and collagen depositions. Moreover, ECS markedly mediated Smad2/3, nuclear factor kappa B (NF-κB) and nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathways both in vitro and vivo. These present findings confirmed that ECS is a novel phenolic glycoside from E. chinensis with promising curative effects on hepatic fibrosis, and its mechanisms may include decreasing extracellular matrix accumulation, reducing inflammation and attenuating free radicals via Smad2/3, NF-κB and Nrf2 signaling pathways, which may shed light on the exploration of more effective phenolic glycoside-based anti-fibrotic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Science, Guangzhou University of Chinese Medicine, Guangzhou, P. R. China.
ORCID-Profile: Jie Yuan, Jie-Wei Wu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, B. L., Liang, H. J., Li, Q. R., Wang, Q., Ao, Z. Y., Fan, Y. W., Zhang, W. J., Lian, X., Chen, J. Y., Yuan, J., & Wu, J. W. (2023). Euryachincoside, a Novel Phenolic Glycoside with Anti-Hepatic Fibrosis Activity from Eurya chinensis. Planta Medica, 89(05), 516-525. https://doi.org/10.1055/a-1828-2671
Vancouver
Li BL, Liang HJ, Li QR, Wang Q, Ao ZY, Fan YW, et al. Euryachincoside, a Novel Phenolic Glycoside with Anti-Hepatic Fibrosis Activity from Eurya chinensis. Planta Medica. 2023;89(05):516-525. doi:10.1055/a-1828-2671
BibTeX
@article{Li2023,
author = {Li, Bai-Lin and Liang, Hui-Jun and Li, Qian-Ran and Wang, Qian and Ao, Zhuo-Yi and Fan, Yu-Wen and Zhang, Wei-Jie and Lian, Xin and Chen, Jia-Yan and Yuan, Jie and Wu, Jie-Wei},
title = {Euryachincoside, a Novel Phenolic Glycoside with Anti-Hepatic Fibrosis Activity from Eurya chinensis},
journal = {Planta Medica},
year = {2023},
volume = {89},
number = {05},
pages = {516--525},
doi = {10.1055/a-1828-2671}
}
EUVIMED